Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.4K Buy
+35,562
New +$61.5K ﹤0.01% 483
2024
Q4
Sell
-51,227
Closed -$50.8K 408
2024
Q3
$50.8K Buy
51,227
+2,815
+6% +$3.86K ﹤0.01% 350
2024
Q2
$75K Buy
+48,412
New +$75.4K ﹤0.01% 311
2023
Q1
Sell
-129,498
Closed -$168K 349
2022
Q4
$168K Sell
129,498
-3,440
-3% -$5.36K 0.01% 310
2022
Q3
$237K Sell
132,938
-25,946
-16% -$64.6K 0.02% 274
2022
Q2
$361K Buy
158,884
+49,396
+45% +$118K 0.03% 206
2022
Q1
$361K Buy
109,488
+77,234
+239% +$271K 0.01% 163
2021
Q4
$147K Buy
32,254
+8,145
+34% +$61.5K 0.01% 278
2021
Q3
$173K Buy
+24,109
New +$177K 0.01% 239
2021
Q1
$94K Buy
+13,866
New +$92.2K 0.01% 243

Other funds holding OCGN

E Fund Management's OCGN Position: Q1 2026 in Review

E Fund Management opened a new position in Ocugen (OCGN) in Q1 2026: 35,562 shares worth $64.4K. The stake represents ﹤0.01% of the portfolio and ranks #483 among its holdings. This is a return to the name: E Fund Management previously reported a position in OCGN as recently as Q3 2024.

E Fund Management first reported a position in OCGN in Q1 2021 and has held it in 10 quarters since. The position peaked at $361K in Q2 2022. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • E Fund Management held 35,562 shares of Ocugen worth $64.4K as of Q1 2026.
  • Ocugen was a new E Fund Management position in Q1 2026.
  • Ocugen made up ﹤0.01% of E Fund Management's portfolio in Q1 2026, its #483 holding.
  • E Fund Management first reported a position in Ocugen in Q1 2021 and has held it in 10 quarters since.
  • E Fund Management's Ocugen position peaked at $361K in Q2 2022.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.